Search

everythinglearnresearchcommunity

for

Search:↓

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

EDA and EDAR are important for hair follicle development in cashmere goats and affect other related genes.

Apremilast improved symptoms in patients with severe skin conditions.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Espumil foam base allows easy preparation of skin medications for hairy areas.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Epimorphin helps shape and develop epithelial cells, like those in hair follicles.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Glyphaea brevis and Monodora myristica can protect against finasteride's harmful effects on blood and oxidative stress in male rats.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.